AbbVie has agreed a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will give it control of a preclinical-stage, oral drug for psoriasis. US-based Nimble was set up in 2019 ...

Here’s something fun from [Chad Kapper] over on HackMakeMod: Escape Room Lockbox with the Cheap Yellow Display. You may have heard of the “cheap yellow display” (CYD), so-called due to the board’s ...

Regeneron could be just a few months away from filing for approval of a therapy for the neuromuscular disorder generalised myasthenia gravis (gMG), cemdisiran, which can be dosed just four times a ...